Skip to content
2000
Volume 24, Issue 1
  • ISSN: 1871-5303
  • E-ISSN: 2212-3873

Abstract

Sarcopenia is becoming prevalent in older or inactive patients, which is placing a heavy burden on the social health system. Studies on the pathogenesis of sarcopenia mainly focus on adipose tissue, myoglobin autophagy, and mitochondrial dysfunction. Up to now, non-drug treatment has been the main way to treat sarcopenia, and there are no drugs specially approved for the treatment of sarcopenia. Here, the pathophysiology and treatment methods of sarcopenia have been summarized, and new drugs for sarcopenia to be researched and developed in the future have been prospected.

Loading

Article metrics loading...

/content/journals/emiddt/10.2174/1871530323666230518105408
2024-01-01
2025-01-18
Loading full text...

Full text loading...

/content/journals/emiddt/10.2174/1871530323666230518105408
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test